Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 2:12:507-524.
doi: 10.2147/HIV.S275314. eCollection 2020.

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies

Daylia Thet  1 , Tippawan Siritientong  1
Affiliations
Review

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies

Daylia Thet et al. HIV AIDS (Auckl). .

Abstract

The extensive utilization of antiretroviral therapy (ART) has successfully improved human immunodeficiency virus (HIV)-associated complications. The incidence of opportunistic infections is decreased by the viral load suppression and the CD4 count promotion. However, metabolic complications, commonly bone demineralization, lipodystrophy, and lactic acidosis, are arising following the adaptation of long-term ART. The events are not drug-specific, but the severity and incidence individually vary depending upon classes of drugs. Such concerning occurrences may lead to discontinuation of current therapy or switching to another regimen with fewer adverse effects. The purpose of this review is to demonstrate the common metabolic abnormalities associated with each class of widely used ART in people living with HIV (PLHIV). Electronic databases such as PubMed, ScienceDirect, Scopus, Google Scholar, SciFinder, and Web of Science were used for the literature search. A better understanding of ART-associated metabolic adverse effects is helpful in various clinical settings so that therapists may optimize treatments in this population.

Keywords: HIV; antiretroviral therapy; lipid profile; lipodystrophy; metabolic.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. UNAIDS. Global HIV & AIDS statistics_2020 fact sheet. 2020. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed July24, 2020.
    1. Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–818. doi:10.1016/S1473-3099(15)00056-0 - DOI - PMC - PubMed
    1. Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3–12. doi:10.1016/j.puhe.2016.05.004 - DOI - PubMed
    1. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res. 2001;51(3):151–177. doi:10.1016/S0166-3542(01)00148-6 - DOI - PubMed
    1. World Health Organization. Update of recommendations on first-and second-line antiretroviral regimens. 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/325892/WHO-CDS-HIV-19.1.... Accessed June13, 2019.